It's mostly because of two things.
One is that companies will invest in markets where they can recoup their investment. That's the crass commercial side of it. So there's nothing in it for the company to introduce it in Canada until such time as they have basically recouped their cost in other countries; we're kind of last on the list. You could do it, but you have to wait until you've actually recovered the costs of the data requirements the government uses to make their decision, until you can sort of expand it and let your competitors come and feed off your plate.
The second part of it is that in Canada we don't have a government philosophy towards self-care. I think I mentioned recently in a speech that the last two health ministers who said that self-care was valuable and we should pursue it were Marc Lalonde and Jake Epp. That's quite a while ago, sad to say. I actually knew both of them, so I've been around a long time, and I know that there is no government self-care initiative.
So if you combine the commercial aspects, which the trade agreement can address, and the government regulatory aspects, then you can really start to fire on all cylinders, just like they do in the U.K.